Full Press Release Details
Immutep successfully completes institutional placement and institutional component of entitlement offer.
IMMP
Immutep successfully completes institutional placement and institutional component of entitlement offer
Key Takeaway: Immutep successfully completes institutional placement and institutional component of entitlement offer
Price reaction · baseline $2.98 (2024-05-31 close) · hit after-hours · 1 other IMMP headline(s) in the window, move may be shared
day 0 close · peak
-12.1%
day 1
-4.4%
day 3
-11.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)